Literature DB >> 2185923

Echocardiography in coronary artery disease.

S Kaul1.   

Abstract

Echocardiography has a major role in the evaluation of patients with CAD. To obtain the maximal amount of information using this technique, certain basic principles relating to regional myocardial mechanics during ischemia and flow-function relations are required. In addition, a detailed knowledge of cardiac anatomy and the three-dimensional orientation of the heart within the chest cavity is required to access meaningful information from two-dimensional planes. Furthermore, skill is also required in acquiring data in proper imaging planes and in separating true (actual pathology) from the false (artifacts, etc.). Echocardiography is not a "mature" technology. It is still developing and it is sometimes difficult to keep up with the advances. However, keeping abreast of these developments is essential to fully exploit the advantages of this technique. In addition, knowledge of the ever-changing aspects of CAD is required in order to correctly interpret visual information in context of a particular patient. Finally, more clinical studies are needed to further define the role of echocardiographic techniques in patients with CAD.

Entities:  

Mesh:

Year:  1990        PMID: 2185923     DOI: 10.1016/0146-2806(90)90012-f

Source DB:  PubMed          Journal:  Curr Probl Cardiol        ISSN: 0146-2806            Impact factor:   5.200


  3 in total

Review 1.  Chest pain: coronary CT in the ER.

Authors:  Erica Maffei; Sara Seitun; Andrea I Guaricci; Filippo Cademartiri
Journal:  Br J Radiol       Date:  2016-02-11       Impact factor: 3.039

Review 2.  Echocardiographic insights into regional flow-function relationships in coronary artery disease.

Authors:  Sanjiv Kaul
Journal:  J Nucl Cardiol       Date:  2005 Mar-Apr       Impact factor: 5.952

Review 3.  Assessment of myocardial viability with two-dimensional echocardiography and magnetic resonance imaging.

Authors:  J R Lindner; S Kaul
Journal:  J Nucl Cardiol       Date:  1996 Mar-Apr       Impact factor: 5.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.